insitro stock

insitro Stock

Looking to sell insitro Stock or Options? Get a free valuation
Founded: 2018Funding to Date: $629M
Visit website

Insitro is a pioneering drug discovery and development company that leverages machine learning and high-throughput biology to generate vast data sets. These data sets are designed to address the pressing challenges in pharmaceutical R&D. Insitro's unique approach enables the creation of predictive models, which are utilized to expedite the selection of drug targets, design and development of potent therapeutics, and to guide clinical strategy, thereby revolutionizing the way drugs are discovered and delivered to patients.

Investors include:
Andreessen Horowitz logo
Further Key Investors:

Foresite Capital, BlackRock, SoftBank Investment Advisers, HOF Capital, TLI Bedrock, Bezos Expeditions, GV, Alexandria Venture Investments, T. Rowe Price, Two Sigma Ventures, A&E Investments, HBM Genomics, Mubadala Capital, Temasek Holdings, Verily Life Sciences, Third Rock Ventures, Globalive Capital, WuXi AppTec, ADS Ventures, CPP Investments, Casdin Capital, ARCH Venture Partners.

Own insitro stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure